23
Hyperemesis Gravidarum Douglas M Montgomery, MD Kaiser Permanente Riverside Medical Center

Hyperemesis6 12

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Hyperemesis6 12

Hyperemesis Gravidarum

Douglas M Montgomery, MD

Kaiser Permanente

Riverside Medical Center

Page 2: Hyperemesis6 12

Diagnosis

Persistent vomiting

Weight loss 5 % pre-pregnancy wt

Ketonuria 3-4 +

Page 3: Hyperemesis6 12

Known Associations

Twins Trophoblastic Dz Triploidy Trisomy 21 Fetal hydrops

Page 4: Hyperemesis6 12

Differential Diagnoses

Goodwin (1998), Clinical Obstetrics and Gynecology 41(3).

Page 5: Hyperemesis6 12

Goodwin (1998), Clinical Obstetrics and Gynecology 41(3).

Page 6: Hyperemesis6 12

Maternal Complications

Wernicke’s Encephalopathy Esophageal tear Mallory-Weiss tear Pneumothorax Peripheral Neuropathy (B6/B12)

Page 7: Hyperemesis6 12

1st Line Treatment

Avoidance of environmental triggers, especially strong odors

Diet Modification (Salty/Sour) Ginger / B 6 / Doxylamine Acupressure wristbands

Page 8: Hyperemesis6 12

Persistent Weight Loss/Vomiting

Drug Choices

Page 9: Hyperemesis6 12

Antihistimines

Dimenhydrinate (dramamine)50 po q 4 Cyclizine(marezine)50 po q 4 Meclizine(antivert)50 po q 24 Promethazine (phenergan)12.5-25 po q 6 or

12.5-25 PR q 12 Diphenhydramine (benadryl)25-50 po q6 Doxylamine (unisom) 12.5 PO q 12 = ½ tab

Page 10: Hyperemesis6 12

Dopamine Receptor Antagonist

PhenothiazinesButyrophenonesBenzamides

Page 11: Hyperemesis6 12

Side Effects of Dopamine Antagonist

extrapyramidal symptoms: dystonia, dyskinesia, akathisia, opisthotonus, and oculogyric crises.

Concurrent benadryl decreases dystonic side effects. Watch for tardive dyskinesia

Page 12: Hyperemesis6 12

Phenothiazines

Prochlorperazine(compazine)10 mg PO q8 or 25 mg PR q 12

Chlorpromazine ( Thorazine ) 25 mg PO q6 or 100 mg PR Q 12

Page 13: Hyperemesis6 12

Butyrophenones

Droperidol (inapsine) 5 mg IM

Haloperidol (haldol)

Page 14: Hyperemesis6 12

Benzamides

Metoclopramide( Reglan) 10 PO q 8

Trimethobenzamide (Tigan) 250 PO q 8

Page 15: Hyperemesis6 12

Serotonin Antagonist

Odansetron ( zofran) 8 mg PO Q12

Page 16: Hyperemesis6 12

Quinlan and Hill, Am Fam Physician. 2003 Jul 1;68

Page 17: Hyperemesis6 12

APGO/UTD

Page 18: Hyperemesis6 12

IV Fluids Consider LR or D5LR solution and  pay close

attention to replenishing vitamins, electrolytes Na/K, and minerals, such as magnesium and phosphorous.

Thiamine supplementation (100 mg IV) is recommended for women who have had prolonged vomiting. Prevent Wernicke’s Encephalopathy with Thiamine prior to Dextrose

Page 19: Hyperemesis6 12

Clinically Significant Nutritional Deficiency

No standard definition for pregnancy The lower the pre-pregnacy weight,

the lower our threshold should be to supplement

10% of pre pregnancy weight loss 180 lbs vs 100 lbs

Page 20: Hyperemesis6 12

PICC Lines

Of 33 patients:

66.4% required treatment for infection and/or thromboembolism

9 % fetal loss rate after first trimester                                                                                         

AJOG 2008;198:56.e1-56.e4

Page 21: Hyperemesis6 12

PICC lines (continued)

Other reports of significant complications:Obstet Gynecol 2006;107• infection precipitated PTD @ 26 weeks with one

NN deathObstet Gynecol  2006;107 • Candida septicemiaAm J Ob Gyn 2003;188 • 50% incidence of infection, thromboembolism or

mechanical failure

Page 22: Hyperemesis6 12

Three separate sources recommend:

Avoid PICC lines Consider Enteral Nutrition alternative 1st Use Parenteral nutrition through a central

line (PICC/HICKMAN) only as a last resort                                                                           

UTD 2008Obstet Gynecol Survey 2008;63Holmgren  AJOG  2008; 198

Page 23: Hyperemesis6 12

Enteral Feeding for Nutritional Support

Two studies support NasoJejunal Feeding One study utilized NG tube One study utilized both NG and ND tube

                                                               

Obstet Gynecol 1996;88:343-6Clinical Nutrition 2004;23,53-7Clinical Nutrition 2001; 20(5): 461-464 AJOG 2008;198:56